The resident pathobiont Staphylococcus xylosus in Nfkbiz-deficient skin accelerates spontaneous skin inflammation

Sci Rep. 2017 Jul 24;7(1):6348. doi: 10.1038/s41598-017-05740-z.

Abstract

IκBζ, which is encoded by the Nfkbiz gene, is a member of the nuclear IκB family of proteins that act as transcriptional regulators via association with NF-κB. Nfkbiz-deficient (Nfkbiz -/-) mice develop spontaneous dermatitis; however, the underlying mechanism has yet to be elucidated. In our study, we found higher skin pathology scores and more serum IgE antibodies and trans-epidermal water loss in Nfkbiz -/- than in Nfkbiz-sufficient (Nfkbiz +/-) mice. There was also greater expansion of IFN-γ-, IL-17A-, and IL-22-secreting CD4+ T cells and of IL-17A-secreting γδ+ T cells in the skin of Nfkbiz -/- mice than in with Nfkbiz +/- mice. Pyrosequencing analysis showed decreased diversity of resident bacteria and markedly expanded Staphylococcus (S.) xylosus in the skin of Nfkbiz -/- mice. Oral administration of antibiotics including cephalexin and enrofloxacin ameliorated skin inflammation. Topical application of S. xylosus also resulted in the expansion of IL-17A-secreting CD4+ T cells along with high levels of pro-inflammatory cytokines and chemokines in the skin of Nfkbiz -/- mice. The expansion of commensal S. xylosus may be one cause of skin dysbiosis in Nfkbiz -/- mice and suggests that the Nfkbiz gene may play a regulatory role in the microbiota-skin immunity axis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / deficiency*
  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • Cephalexin / therapeutic use
  • Dermatitis / drug therapy
  • Dermatitis / genetics
  • Dermatitis / microbiology
  • Dermatitis / pathology*
  • Disease Models, Animal
  • Enrofloxacin / therapeutic use
  • Humans
  • Immunoglobulin E / blood
  • Mice
  • Nuclear Proteins / deficiency*
  • Sequence Analysis, DNA
  • Skin / microbiology
  • Skin / pathology*
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / genetics
  • Staphylococcal Infections / pathology
  • Staphylococcus / classification
  • Staphylococcus / isolation & purification*
  • Staphylococcus / pathogenicity
  • Symbiosis

Substances

  • Adaptor Proteins, Signal Transducing
  • Nfkbiz protein, mouse
  • Nuclear Proteins
  • Immunoglobulin E
  • Enrofloxacin
  • Cephalexin